# Interview Tracking - Oncology QSP Platform Validation

**Target:** 10 completed interviews by October 31, 2025  
**Focus:** Oncology QSP platform need validation

---

## Interview Progress

| # | Name | Company | Title | Source | Date | Status | Key Insights |
|---|------|---------|-------|---------|------|---------|--------------|
| 1 | | | | OSP/LinkedIn | | | |
| 2 | | | | OSP/LinkedIn | | | |
| 3 | | | | OSP/LinkedIn | | | |
| 4 | | | | OSP/LinkedIn | | | |
| 5 | | | | OSP/LinkedIn | | | |
| 6 | | | | OSP/LinkedIn | | | |
| 7 | | | | OSP/LinkedIn | | | |
| 8 | | | | OSP/LinkedIn | | | |
| 9 | | | | OSP/LinkedIn | | | |
| 10| | | | OSP/LinkedIn | | | |

---

## Validation Summary (Update After Every 3 Interviews)

### Oncology Specialization Value
- **Pain Points Validated:** [Count recognizing oncology-specific challenges]
- **General vs Specialized:** [Preference for cancer-specific vs general tools]
- **Cancer Types:** [Most commonly worked on]

### Platform Requirements  
- **Must-Have Features:** [List]
- **Integration Needs:** [OSP Suite, Phoenix, other]
- **Regulatory Requirements:** [Documentation, audit trails]

### Business Validation
- **Budget Range:** [Typical for specialized software]
- **Decision Process:** [Who decides, how long]
- **Switching Drivers:** [What would cause tool change]

---

## Decision Criteria (After 10 Interviews)

**Proceed with Oncology Platform if:**
- 70%+ validate oncology-specific modeling challenges
- Clear preference for specialized vs general tools
- Budget willingness in $500-2500/month range
- 30%+ interested in beta testing

**Modify Strategy if:**
- Mixed signals on specialization value
- Budget constraints require pricing adjustment
- Feature priorities different than expected

---

This simplified tracking focuses only on the essential validation metrics for the platform decision.